{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:11:10Z","timestamp":1778505070999,"version":"3.51.4"},"reference-count":43,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RIA2017S-2007"],"award-info":[{"award-number":["RIA2017S-2007"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2026,4,4]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"\n Background<\/jats:title>\n Timely and appropriate diagnosis and treatment are key to ending tuberculosis (TB). Incorporating users\u2019 preferences when implementing decentralised strategies for diagnosis may facilitate scale-up and impact. This qualitative study embedded within a cluster randomised controlled trial explored the values and preferences of multiple stakeholders regarding a TB diagnostic strategy using the Truenat platform, mycobacterium tuberculosis (MTB) Plus and rifampicin Dx Assays in Mozambique and Tanzania.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted semi-structured interviews with people with presumptive TB (n=35), professional users (laboratory technicians, nurses, clinicians, n=19) and national decision-makers (n=5). Direct observations of testing procedures and usability surveys (n=12) were also conducted. Thematic analysis was performed, informed by the Consolidated Framework for Implementation Research.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Facilities varied in testing capacity, number of cases and time-to-results (from same-day to >2 weeks). Availability and supply of reagents and cartridges were described as an issue by healthcare providers and a potential cause for delayed results. The Truenat platform for detection of TB was considered easy to use (median SUS score 90\/100) as well as acceptable and fit to the context where the evaluation was conducted. Truenat\u2019s advantage was appreciated in facilities with limited prior testing capacity (eg, shipping samples, using microscopy), including short time-to-results, reduced need to return to provide more samples and fewer infrastructure needs (compared with GeneXpert). People with presumptive TB preferred the same-day results and rapid initiation of treatment enabled by Truenat testing. Some viewed waiting longer time (>1\u2009day) for the results acceptable if it were to result in increased accuracy. Regarding the diagnostic process, participants valued the support and counselling from the healthcare workers.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The Truenat platform and TB assays were perceived as easy to use by health providers, and as acceptable and feasible across stakeholder groups. Its implementation in decentralised settings was considered a preferred alternative to off-site Xpert testing for TB in Mozambique and Tanzania.<\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n NCT04568954<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-019902","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:30:21Z","timestamp":1778502621000},"page":"e019902","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and Tanzania"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04568954","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-2919","authenticated-orcid":false,"given":"Maria del Mar","family":"Castro","sequence":"first","affiliation":[{"name":"Department of Infectious Disease and Tropical Medicine, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"Partner Site Heidelberg, German Center for Infection Research (DZIF), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso","family":"Khosa","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade, Marracuene, Mozambique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Mhalu","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Ifakara, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lonze","family":"Ndelwa","sequence":"additional","affiliation":[{"name":"Mbeya Medical Research Centre (MMRC), National Institute for Medical Research, Dar es Salaam, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeon","family":"Mwanyonga","sequence":"additional","affiliation":[{"name":"Mbeya Medical Research Centre (MMRC), National Institute for Medical Research, Dar es Salaam, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thresphory","family":"Zumba","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Ifakara, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9lio","family":"El\u00edsio","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a, Manhica, Mozambique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Magul","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a, Manhica, Mozambique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Manganhe","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade, Marracuene, Mozambique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Machiana","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade, Marracuene, Mozambique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Cossa","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a, Manhica, Mozambique"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Edom","sequence":"additional","affiliation":[{"name":"Mbeya Medical Research Centre (MMRC), National Institute for Medical Research, Dar es Salaam, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Hella","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute, Ifakara, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinis","family":"Nguenha","sequence":"additional","affiliation":[{"name":"Centro de Investiga\u00e7\u00e3o em Sa\u00fade de Manhi\u00e7a, Manhica, Mozambique"},{"name":"University of Amsterdam, Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Ruhwald","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinzeigh","family":"Leukes","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Penn-Nicholson","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kranzer","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Tropical Medicine,LMU University Hospital, LMU Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7216-7067","authenticated-orcid":false,"given":"Claudia M","family":"Denkinger","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Tropical Medicine, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"Partner Site Heidelberg, German Center for Infection Research (DZIF), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2026051105300820000_11.5.e019902.1","unstructured":"World Health Organization . Global tuberculosis report 2024. Contract No.: ISBN: 978-92-4-010153-1. Geneva World Health Organization. 2024."},{"key":"2026051105300820000_11.5.e019902.2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2010.199505"},{"key":"2026051105300820000_11.5.e019902.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100603","article-title":"The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis","volume":"28","author":"Cilloni","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2026051105300820000_11.5.e019902.4","unstructured":"World Health Organization . The end TB strategy. 2015. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/the-end-tb-strategy"},{"key":"2026051105300820000_11.5.e019902.5","article-title":"Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views","volume":"4","author":"Engel","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051105300820000_11.5.e019902.6","unstructured":"Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF system. WHO guidelines approved by the guidelines review committee. Geneva, 2011."},{"key":"2026051105300820000_11.5.e019902.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00543-2016"},{"key":"2026051105300820000_11.5.e019902.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-020-4997-x","article-title":"Challenges with scale-up of GeneXpert MTB\/RIF\u00ae in Uganda: a health systems perspective","volume":"20","author":"Nalugwa","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2026051105300820000_11.5.e019902.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001179","article-title":"The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes: A diagnostic network optimization analysis in Zambia","volume":"3","author":"Girdwood","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"2026051105300820000_11.5.e019902.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004612","article-title":"WHO target product profile for TB detection at peripheral settings: 2024 update","volume":"5","author":"Kohli","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"2026051105300820000_11.5.e019902.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105991","article-title":"Diagnostic accuracy of swab-based molecular tests for tuberculosis using near-point-of-care platforms: a multi-country evaluation","volume":"121","author":"Steadman","year":"2025","journal-title":"EBioMedicine"},{"key":"2026051105300820000_11.5.e019902.12","doi-asserted-by":"crossref","first-page":"1278716","DOI":"10.3389\/fmed.2023.1278716","article-title":"Diagnostic accuracy of oral swab for detection of pulmonary tuberculosis: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Med"},{"key":"2026051105300820000_11.5.e019902.13","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.lanmic.2024.100963","article-title":"Performance of stool-based molecular tests and processing methods for paediatric tuberculosis diagnosis: a systematic review and meta-analysis","volume":"6","author":"Carratal\u00e0-Castro","year":"2025","journal-title":"Lancet Microbe"},{"key":"2026051105300820000_11.5.e019902.14","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1016\/S2214-109X(23)00135-3","article-title":"Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data","volume":"11","author":"Broger","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2026051105300820000_11.5.e019902.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-06164-w","article-title":"Comparing the accuracy of computer-aided detection (CAD) software and radiologists from multiple countries for tuberculosis detection in chest X-Rays","volume":"15","author":"Qin","year":"2025","journal-title":"Sci Rep"},{"key":"2026051105300820000_11.5.e019902.16","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/S2589-7500(24)00118-3","article-title":"Computer-aided detection of tuberculosis from chest radiographs in a tuberculosis prevalence survey in South Africa: external validation and modelled impacts of commercially available artificial intelligence software","volume":"6","author":"Qin","year":"2024","journal-title":"Lancet Digit Health"},{"key":"2026051105300820000_11.5.e019902.17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00526-2021","article-title":"A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays","volume":"58","author":"Penn-Nicholson","year":"2021","journal-title":"Eur Respir J"},{"key":"2026051105300820000_11.5.e019902.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003652","article-title":"Perceived ease of use of Truenat among laboratory staff as a new diagnostic tool for TB in Nigeria: Result of a pilot roll-out","volume":"4","author":"Ihesie","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026051105300820000_11.5.e019902.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12961-018-0320-2","article-title":"The GRADE Evidence to Decision (EtD) framework for health system and public health decisions","volume":"16","author":"Moberg","year":"2018","journal-title":"Health Res Policy Syst"},{"key":"2026051105300820000_11.5.e019902.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08876-8","article-title":"Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform\/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE)","volume":"24","author":"Leukes","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026051105300820000_11.5.e019902.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7"},{"key":"2026051105300820000_11.5.e019902.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated Consolidated Framework for Implementation Research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"2026051105300820000_11.5.e019902.23","unstructured":"International Organization for Standardization . Ergonomics of human-system interaction \u2014 Part 11: usability: definitions and concepts. 2018."},{"key":"2026051105300820000_11.5.e019902.24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/10447310802205776","article-title":"An Empirical Evaluation of the System Usability Scale","volume":"24","author":"Bangor","year":"2008","journal-title":"Int J Hum-Comput Interact"},{"key":"2026051105300820000_11.5.e019902.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000837","article-title":"Systematic debriefing after qualitative encounters: an essential analysis step in applied qualitative research","volume":"3","author":"McMahon","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2026051105300820000_11.5.e019902.26","unstructured":"Braun V , Analysis CVT . Thematic analysis. A practical guide. Sage, 2021."},{"key":"2026051105300820000_11.5.e019902.27","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"2026051105300820000_11.5.e019902.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4115-z","article-title":"Waiting to inhale: factors associated with healthcare workers\u2019 fears of occupationally-acquired tuberculosis (TB)","volume":"19","author":"Engelbrecht","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026051105300820000_11.5.e019902.29","unstructured":"Stop TB Partnership . Country experiences: stop TB partnership. 2024. Available: https:\/\/www.stoptb.org\/introducing-new-tools-project\/country-experiences [Accessed 21 Oct 2024]."},{"key":"2026051105300820000_11.5.e019902.30","unstructured":"Infectious Disease Detection and Surveillance (IDDS) project. Report on Truenat pilot in Cambodia, including best practices for successful Truenat implementation. 2024."},{"key":"2026051105300820000_11.5.e019902.31","unstructured":"The introducting new tools project (iNTP). Early experience of the democratic Republic of the Congo in implementation of Truenat MTB plus and MTB-RIF Dx testing. 2023."},{"key":"2026051105300820000_11.5.e019902.32","unstructured":"The introducting new tools project (iNTP). Introducing Truenat testing in peripheral facilities: lessons learned from Bangladesh. 2023."},{"key":"2026051105300820000_11.5.e019902.33","doi-asserted-by":"crossref","first-page":"100028","DOI":"10.1016\/j.lanprc.2025.100028","article-title":"Implementing the Molbio Truenat platform and tuberculosis assays versus standard of care at primary care clinics for the detection and treatment of tuberculosis in Mozambique and Tanzania (TB-CAPT CORE): a cluster-randomised trial","volume":"1","author":"Khosa","year":"2025","journal-title":"The Lancet Primary Care"},{"key":"2026051105300820000_11.5.e019902.34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2025-019092","article-title":"Preferences for tongue swab-based versus sputum-based testing in the context of TB care: a best-worst scaling exercise in Vietnam and Zambia","volume":"10","author":"Castro","year":"2025","journal-title":"BMJ Glob Health"},{"key":"2026051105300820000_11.5.e019902.35","doi-asserted-by":"crossref","unstructured":"Castro M del M , Le H , Manoj Kumar K , et al . Informing People-Centered Target Product Profiles for TB Diagnostics: A Multi-Country Qualitative Study. medRxiv [Preprint]. doi:10.1101\/2025.07.11.25331385","DOI":"10.1101\/2025.07.11.25331385"},{"key":"2026051105300820000_11.5.e019902.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058805","article-title":"Experiences and perceptions of urine sampling for tuberculosis testing among HIV patients: a multisite qualitative descriptive study","volume":"13","author":"Lissouba","year":"2023","journal-title":"BMJ Open"},{"key":"2026051105300820000_11.5.e019902.37","doi-asserted-by":"crossref","first-page":"100012","DOI":"10.1016\/j.lanprc.2025.100012","article-title":"Preferences for tuberculosis diagnostic test features among people tested for tuberculosis: a multicountry discrete choice experiment","volume":"1","author":"Shah","year":"2025","journal-title":"The Lancet Primary Care"},{"key":"2026051105300820000_11.5.e019902.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001430","article-title":"Preferences of healthcare workers using tongue swabs for tuberculosis diagnosis during COVID-19","volume":"3","author":"Codsi","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"2026051105300820000_11.5.e019902.39","unstructured":"MSF . J&J and Cepheid must expand access to TB drug and tests. 2023. Available: https:\/\/www.doctorswithoutborders.org\/latest\/jj-and-cepheid-must-expand-access-tb-drug-and-tests"},{"key":"2026051105300820000_11.5.e019902.40","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000053"},{"key":"2026051105300820000_11.5.e019902.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004724","article-title":"Decentralized TB diagnostic testing with Truenat MTB Plus and MTB-RIF Dx vs. hub-and-spoke GeneXpert MTB\/RIF Ultra in Mozambique and Tanzania: a cost and cost-effectiveness analysis","volume":"5","author":"Malhotra","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"2026051105300820000_11.5.e019902.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000672","article-title":"User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)-a qualitative study in Malawi and Zambia","volume":"2","author":"Herrmann","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026051105300820000_11.5.e019902.43","unstructured":"heiDATA . Heidelberg open research data Heidelberg. Germany Heidelberg University; 2025. Available: https:\/\/heidata.uni-heidelberg.de"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-019902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:30:43Z","timestamp":1778502643000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-019902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,11]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjgh-2025-019902"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-019902","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}